Veradermics, Incorporated (MANE)

Veradermics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Net Income	-0.05	-0.03	-0.02
Share-Based Compensation	-	0	0
Other Operating Activities	0	0	0
Operating Cash Flow	-0.05	-0.02	-0.01
Share Issuance / Repurchase	-	0.05	0.01
Debt Issued / Paid	-	0.01	-
Financing Cash Flow	0.06	0.06	0.01
Net Cash Flow	-0	0.04	0
Free Cash Flow	-0.05	-0.02	-0.01

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).